European Neuropsychopharmacology

1-110 of 110
 
Check/Uncheck all
  • 2025 | Journal Article
    ​ ​Contrasting genetic burden for bipolar disorder: Early onset versus late onset in an older adult bipolar disorder sample​
    Montejo, L.; Sole, B.; Fico, G.; Kalman, J. L.; Budde, M.; Heilbronner, U. & Oliva, V. et al.​ (2025) 
    European Neuropsychopharmacology, 92 pp. 29​-37​.​ DOI: https://doi.org/10.1016/j.euroneuro.2024.12.001 
    ​Details  DOI 
  • 2024 | Journal Article
    ​ ​Effect of erythropoietin on cognitive side-effects of electroconvulsive therapy in depression: A randomized, double-blind, placebo-controlled trial​
    Miskowiak, K. W.; Petersen, J. Z.; Macoveanu, J.; Ysbæk-Nielsen, A. T.; Lindegaard, I. A.; Cramer, K. & Mogensen, M. B. et al.​ (2024) 
    European Neuropsychopharmacology, 79 pp. 38​-48​.​ DOI: https://doi.org/10.1016/j.euroneuro.2023.12.004 
    ​Details  DOI 
  • 2024 | Journal Article
    ​ ​F21. EFFECTS OF POLYGENIC SCORES FOR A COMMON EXECUTIVE FUNCTION FACTOR ON THE LONGITUDINAL COURSE OF EXECUTIVE FUNCTIONS​
    Navarro-Flores, A.; Heilbronner, M.; Rafiee, H.; Wendel, B.; Papiol, S.; Adorjan, K. & Budde, M. et al.​ (2024) 
    European Neuropsychopharmacology, 87 pp. 216​-217​.​ DOI: https://doi.org/10.1016/j.euroneuro.2024.08.432 
    ​Details  DOI 
  • 2023 | Journal Article
    ​ ​F86. INTEGRATIVE ANALYSIS OF MICRORNA EXPRESSION PROFILES REVEALS POTENTIAL MOLECULAR MECHANISMS UNDERLYING BROAD DIAGNOSTIC GROUPS​
    Poschmann, J.; Solomon, P.; Heilbronner, U.; Budde, M.; Kaurani, L.; Guiné, J.-B. & Fischer, A. et al.​ (2023) 
    European Neuropsychopharmacology, 75 pp. S266​.​ DOI: https://doi.org/10.1016/j.euroneuro.2023.08.468 
    ​Details  DOI 
  • 2022 | Journal Article
    ​ ​Contribution of Polygenic Scores for a “Common Executive Function” Factor to Cognitive Performance in the Psycourse Study​
    Wendel, B.; Heilbronner, M.; Papiol, S.; Adorjan, K.; Budde, M.; Kalman, J. L. & Kohshour, M. O. et al.​ (2022) 
    European Neuropsychopharmacology, 63 art. e137​.​ DOI: https://doi.org/10.1016/j.euroneuro.2022.07.254 
    ​Details  DOI 
  • 2021 | Journal Article
    ​ ​P.0693 Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range​
    Eichentopf, L.; Hiemke, C.; Hefner, G.; Schoretsanitis, G.; Kuzin, M.; Zernig, G. & Havemann-Reinecke, U. et al.​ (2021) 
    European Neuropsychopharmacology, 53 pp. S507​-S508​.​ DOI: https://doi.org/10.1016/j.euroneuro.2021.10.653 
    ​Details  DOI 
  • 2021 | Journal Article
    ​ ​The myth that psychotherapy is more effective than pharmacotherapy in anxiety disorders​
    Bandelow, B.​ (2021) 
    European Neuropsychopharmacology, 49 pp. 116​-118​.​ DOI: https://doi.org/10.1016/j.euroneuro.2021.04.012 
    ​Details  DOI 
  • 2021 | Journal Article
    ​ ​Neuroimaging evidence for structural correlates in adolescents resilient to polysubstance use: A five-year follow-up study​
    Filippi, I.; Galinowski, A.; Lemaître, H.; Massot, C.; Zille, P.; Frère, P. & Miranda-Marcos, R. et al.​ (2021) 
    European Neuropsychopharmacology, 49 pp. 11​-22​.​ DOI: https://doi.org/10.1016/j.euroneuro.2021.03.001 
    ​Details  DOI 
  • 2021 | Journal Article
    ​ ​MMP9 mRNA is a potential diagnostic and treatment monitoring marker for PTSD: Evidence from mice and humans​
    Chevalier, C. M.; Krampert, L.; Schreckenbach, M.; Schubert, C. F.; Reich, J.; Novak, B. & Schmidt, M. V. et al.​ (2021) 
    European Neuropsychopharmacology, 51 pp. 20​-32​.​ DOI: https://doi.org/10.1016/j.euroneuro.2021.04.014 
    ​Details  DOI 
  • 2021 | Journal Article
    ​ ​A GWAS top hit for circulating leptin is associated with weight gain but not with leptin protein levels in lithium-augmented patients with major depression​
    Bopp, S. K; Heilbronner, U.; Schlattmann, P.; Buspavanich, P. J; Lang, U. E; Heinz, A. & Schulze, T. G et al.​ (2021) 
    European Neuropsychopharmacology, 53 pp. 114​-119​.​ DOI: https://doi.org/10.1016/j.euroneuro.2021.09.007 
    ​Details  DOI 
  • 2021 | Journal Article
    ​ ​P.0343 Early detection, diagnosis and intervention services for children with autism spectrum disorder across europe according to the gross domestic product​
    Bejarano-Martín, Á.; Canal-Bedia, R.; Magán-Maganto, M.; Fernández-Álvarez, C.; Martín-Cilleros, M.; Sánchez-Gómez, M. & García-Primo, P. et al.​ (2021) 
    European Neuropsychopharmacology, 53 pp. S249​-S250​.​ DOI: https://doi.org/10.1016/j.euroneuro.2021.10.326 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Clinical application of genomic high-throughput data: Infrastructural, ethical, legal and psychosocial aspects​
    Umbach, N.; Beißbarth, T. ; Bleckmann, A.; Duttge, G.; Flatau, L.; König, A. & Kuhn, J. et al.​ (2020) 
    European Neuropsychopharmacology, 31 pp. 1​-15​.​ DOI: https://doi.org/10.1016/j.euroneuro.2019.09.008 
    ​Details  DOI  PMID  PMC 
  • 2020 | Journal Article
    ​ ​A neurobiological framework of separation anxiety and related phenotypes​
    Schiele, M. A.; Bandelow, B. ; Baldwin, D. S.; Pini, S. & Domschke, K.​ (2020) 
    European Neuropsychopharmacology, 33 pp. 45​-57​.​ DOI: https://doi.org/10.1016/j.euroneuro.2020.01.009 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​P.009 MDK gene expression is correlated with human brain activity during acceptance of monetary rewards​
    Komorowski, A.; Singh, A. ; Vidal, R. ; Murgaš, M.; Pena-Centeno, T. ; Gryglewski, G. & Kasper, S. et al.​ (2020) 
    European Neuropsychopharmacology, 40 pp. S6​-S7​.​ DOI: https://doi.org/10.1016/j.euroneuro.2020.09.015 
    ​Details  DOI 
  • 2019 | Journal Article | 
    ​ ​Efficient region-based test strategy uncovers genetic risk factors for functional outcome in bipolar disorder​
    Budde, M.; Friedrichs, S.; Alliey-Rodriguez, N.; Ament, S.; Badner, J. A.; Berrettini, W. H. & Bloss, C. S. et al.​ (2019) 
    European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology, 29(1) pp. 156​-170​.​ DOI: https://doi.org/10.1016/j.euroneuro.2018.10.005 
    ​Details  DOI  PMID  PMC 
  • 2019 | Journal Article | 
    ​ ​Women using hormonal contraceptives show increased valence ratings and memory performance for emotional information​
    Spalek, K.; Loos, E.; Schicktanz, N.; Hartmann, F.; de Quervain, D.; Stier, C. & Milnik, A.​ (2019) 
    Neuropsychopharmacology,.​ DOI: https://doi.org/10.1038/s41386-019-0362-3 
    ​Details  DOI  PMID  PMC 
  • 2019 | Journal Article
    ​ ​T19DEVELOPING AND EVALUATING A STANDARDIZED, MACHINE LEARNING WORKFLOW FOR PREDICTING PSYCHIATRIC PHENOTYPES USING GENOME-WIDE AND CLINICAL DATA​
    Marshe, V.; Hauschild, A.-C. ; Maciukiewicz, M. & Mueller, D.​ (2019) 
    European Neuropsychopharmacology, 29 pp. S228​-S229​.​ DOI: https://doi.org/10.1016/j.euroneuro.2019.08.218 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​F24SYSTEMS BIOLOGY APPROACH TO EVALUATE GENETIC FACTORS OF ANTIPSYCHOTIC INDUCED WEIGHT GAIN IN PATIENTS WITH SCHIZOPHRENIA​
    Hauschild, A.-C. ; Maciukiewicz, M.; Tiwari, A.; Zai, C.; Liebermann, J. A.; Meltzer, H. & Kennedy, J. L. et al.​ (2019) 
    European Neuropsychopharmacology, 29 pp. S1122​.​ DOI: https://doi.org/10.1016/j.euroneuro.2018.08.104 
    ​Details  DOI 
  • 2019 | Journal Article | Research Paper
    ​ ​P.2.02 Bottom-up versus top-down attention during working memory encoding: A functional magnetic resonance imaging study​
    Qubad, M.; Barnes-Scheufler, C.; Roesler, L.; Schaum, M.; Peters, B.; Wibral, M.   & Reif, A. et al.​ (2019) 
    European Neuropsychopharmacology, 29 pp. S655​-S656​.​ DOI: https://doi.org/10.1016/j.euroneuro.2019.01.033 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​P.189 Genetic substrates of task-specific functional magnetic resonance imaging activation during acceptance of monetary rewards​
    Komorowski, A.; Singh, A. ; Vidal, R. O. ; Murgaš, M.; Pena-Centeno, T.; Gryglewski, G. & Kasper, S. et al.​ (2019) 
    European Neuropsychopharmacology, 29 pp. S145​.​ DOI: https://doi.org/10.1016/j.euroneuro.2019.09.233 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​P.392 Hospitalization rates and therapy costs of German schizophrenia patients who are initiated on long acting injectable medication​
    Wimmer, A.; Mahlich, J.; Olbrich, K. & Wolff-Menzler, C. ​ (2019) 
    European Neuropsychopharmacology, 29 pp. S278​.​ DOI: https://doi.org/10.1016/j.euroneuro.2019.09.406 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​SU107MULTIPLE ENVIRONMENTAL HITS BEFORE ADULTHOOD PREDICT VIOLENT AGGRESSION​
    Mitjans, M.; Seidel, J.; Begemann, M. ; Bockhop, F.; Seelbach, A.; Bansal, V. & Wesolowski, J. et al.​ (2019) 
    European Neuropsychopharmacology, 29 pp. S1323​.​ DOI: https://doi.org/10.1016/j.euroneuro.2018.08.471 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​SA88PSYCOURSE: A TRANSDIAGNOSTIC STUDY ON THE COURSE OF SEVERE MENTAL DISORDERS​
    Budde, M. ; Gade, K. ; Anderson-Schmidt, H. ; Kalman, J.; Senner, F.; Adorjan, K. & Schulte, E. C. et al.​ (2019) 
    European Neuropsychopharmacology, 29 pp. S1236​.​ DOI: https://doi.org/10.1016/j.euroneuro.2018.08.310 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​SU62THE ROLE OF ENVIRONMENTAL STRESS AND DNA METHYLATION IN THE LONGITUDINAL COURSE OF BIPOLAR DISORDER​
    Comes, A.; Adorjan, K.; Andlauer, T.; Budde, M. ; Degenhardt, F.; Forstner, A. J. & Gade, K.  et al.​ (2019) 
    European Neuropsychopharmacology, 29 pp. S1300​-S1301​.​ DOI: https://doi.org/10.1016/j.euroneuro.2018.08.426 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Cortisol response to nocturnal psychosocial stress in dependence of CRHR1 genotype​
    Weeger, J.; Schmidt, U.; Uhr, M. & Steiger, A.​ (2019) 
    European Neuropsychopharmacology, 29 pp. S525​-S526​.​ DOI: https://doi.org/10.1016/j.euroneuro.2018.11.779 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​F129EXOME SEQUENCING WITH SUBSEQUENT MULTI-TIER ANALYSES IN A LARGE COHORT OF MULTIPLY AFFECTED FAMILIES PROVIDES NEW INSIGHT INTO SCHIZOPHRENIA​
    Koller, A.; Greve, C.; Kaurani, L. ; Klockmeier, K.; Degenhardt, F. C.; Maaser, A. & Forstner, A. J. et al.​ (2019) 
    European Neuropsychopharmacology, 29 pp. S1180​-S1181​.​ DOI: https://doi.org/10.1016/j.euroneuro.2018.08.209 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​SA125POLYGENIC BURDEN ANALYSIS OF LONGITUDINAL CLUSTERS OF PSYCHOPATHOLOGICAL FEATURES IN A CROSS-DIAGNOSTIC GROUP OF INDIVIDUALS WITH SEVERE MENTAL ILLNESS​
    Schulte, E.; Kondofersky, I.; Budde, M. ; Adorjan, K.; Aldinger, F.; Anderson-Schmidt, H.   & Gade, K.  et al.​ (2019) 
    European Neuropsychopharmacology, 29 pp. S1257​-S1258​.​ DOI: https://doi.org/10.1016/j.euroneuro.2018.08.347 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​F96POLYGENIC RISK SCORE ANALYSIS OF TRAJECTORIES OF COGNITIVE PERFORMANCE IN PSYCHIATRIC PATIENTS​
    Schaupp, S.; Budde, M. ; Kondofersky, I.; Papiol, S. ; Heilbronner, U. ; Gade, K.   & Anderson-Schmidt, H.  et al.​ (2019) 
    European Neuropsychopharmacology, 29 pp. S1161​.​ DOI: https://doi.org/10.1016/j.euroneuro.2018.08.176 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​POLYGENIC RISK BURDEN AND CANNABIS USE COMORBIDITY IN PATIENTS WITH SCHIZOPHRENIA AND BIPOLAR DISORDER​
    Adorjan, K.; Papiol, S. ; Gade, K. ; Malzahn, D. ; Sherva, R.; Budde, M.   & Aldinger, F. et al.​ (2019) 
    European Neuropsychopharmacology, 29 pp. S951​.​ DOI: https://doi.org/10.1016/j.euroneuro.2017.08.302 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Disparate effects of first and second generation antipsychotics on cognition in schizophrenia – Findings from the randomized NeSSy trial​
    Veselinović, T.; Scharpenberg, M.; Heinze, M.; Cordes, J.; Mühlbauer, B.; Juckel, G. & Habel, U. et al.​ (2019) 
    European Neuropsychopharmacology, 29(6) pp. 720​-739​.​ DOI: https://doi.org/10.1016/j.euroneuro.2019.03.014 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​M44 COGNITIVE PERFORMANCE IN THE PSYCOURSE STUDY: THE AFFECTIVE-TO-PSYCHOTIC SPECTRUM AND ITS ASSOCIATION WITH POLYGENIC RISK SCORES FOR SEVERE MENTAL ILLNESSES​
    Budde, M. ; Schaupp, S. K.; Comes, A. L.; Papiol, S. ; Yoshida, T.; Adorjan, K. & Anderson-Schmidt, H.  et al.​ (2019) 
    European Neuropsychopharmacology, 29 pp. S189​.​ DOI: https://doi.org/10.1016/j.euroneuro.2019.08.144 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​96 LIPIDOME ANALYSIS IN INDIVIDUALS WITH SCHIZOPHRENIA REVEALS CHARACTERISTIC PLASMA LIPID PROFILES​
    Schulte, E.; Tkachev, A.; Adorjan, K.; Anderson-Schmidt, H. ; Budde, M. ; Gade, K.   & Heilbronner, U.  et al.​ (2019) 
    European Neuropsychopharmacology, 29 pp. S113​.​ DOI: https://doi.org/10.1016/j.euroneuro.2019.07.237 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​SU53A CROSS-DIAGNOSTIC GWAS OF LONGITUDINAL EXECUTIVE FUNCTION PROFILE SCORES​
    Heilbronner, U. ; Wendel, B.; Budde, M. ; Gade, K. ; Adorjan, K.; Kalman, J. & Senner, F. et al.​ (2019) 
    European Neuropsychopharmacology, 29 pp. S1295​-S1296​.​ DOI: https://doi.org/10.1016/j.euroneuro.2018.08.417 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Leptin gene polymorphisms are associated with weight gain during lithium augmentation in patients with major depression​
    Bopp, S. K.; Heilbronner, U. ; Schlattmann, P.; Mühleisen, T. W.; Bschor, T.; Richter, C. & Steinacher, B. et al.​ (2019) 
    European Neuropsychopharmacology, 29(2) pp. 211​-221​.​ DOI: https://doi.org/10.1016/j.euroneuro.2018.12.006 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​EXOME-SEQUENCING IN DENSLY AFFECTED PEDIGREES IDENTIFIES NEW CANDIDATE GENES FOR SCHIZOPHRENIA​
    Degenhardt, F.; Koller, A. C.; Kaurani, L. ; Worf, K.; Degenhardt, F. C.; Klockmeier, K. & Andlauer, T. et al.​ (2019) 
    European Neuropsychopharmacology, 29 pp. S1005​.​ DOI: https://doi.org/10.1016/j.euroneuro.2017.08.399 
    ​Details  DOI 
  • 2019 | Journal Article | Research Paper
    ​ ​SA24NETBI-OMICS – Data Exchange for Distributed Biobanks in The Investigation of Mental Illness​
    Senner, F.; Pung, J. ; Rietschel, M.; Witt, S.; Rienhoff, O. & Schulze, T.​ (2019) 
    European Neuropsychopharmacology, 29 pp. S1200​-S1201​.​ DOI: https://doi.org/10.1016/j.euroneuro.2018.08.246 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​P.239 Electroconvulsive therapy and the brain: no increase of neurofilament light chain in the treatment course​
    Zilles, D. ; Besse, M. ; Folsche, T.; Methfessel, I. ; Belz, M. ; Vogelgsang, J. & Wiltfang, J. ​ (2019) 
    European Neuropsychopharmacology, 29 pp. S183​-S184​.​ DOI: https://doi.org/10.1016/j.euroneuro.2019.09.281 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​POLYGENIC BURDEN ANALYSIS OF LONGITUDINAL CLUSTERS OF PSYCHOPATHOLOGICAL FEATURES IN A CROSS-DIAGNOSTIC GROUP OF INDIVIDUALS WITH SEVERE MENTAL ILLNESS​
    Schulte, E.; Kondofersky, I.; Budde, M. ; Adorjan, K.; Aldinger, F.; Anderson-Schmidt, H.   & Andlauer, T. F. et al.​ (2019) 
    European Neuropsychopharmacology, 29 pp. S995​-S996​.​ DOI: https://doi.org/10.1016/j.euroneuro.2017.08.382 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​THE IMPACT OF BIPOLAR AND SCHIZOPHRENIA POLYGENIC RISK SCORES ON FAMILIAL FEATURES OF BIPOLAR DISORDER​
    Gade, K. ; Papiol, S. ; Heilbronner, U. ; Budde, M. ; Adorjan, K.; Anderson-Schmidt, H.   & Kalman, J. et al.​ (2019) 
    European Neuropsychopharmacology, 29 pp. S968​.​ DOI: https://doi.org/10.1016/j.euroneuro.2017.08.333 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​EFFECTS OF SCHIZOPHRENIA AND BIPOLAR POLYGENIC RISK SCORES ON AGE AT ONSET IN BIPOLAR DISORDER​
    Kalman, J.; Papiol, S. ; Heilbronner, U. ; Andlauer, T. F.; Anderson-Schmidt, H. ; Budde, M.   & Gade, K.  et al.​ (2019) 
    European Neuropsychopharmacology, 29 pp. S967​.​ DOI: https://doi.org/10.1016/j.euroneuro.2017.08.331 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​S46A GENOME-WIDE ASSOCIATION STUDY OF THE LONGITUDINAL COURSE OF EXECUTIVE FUNCTIONS​
    Heilbronner, U.; Wendel, B.; Budde, M.; Gade, K.; Adorjan, K.; Kalman, J. & Senner, F. et al.​ (2019) 
    European Neuropsychopharmacology, 29 pp. S137​-S138​.​ DOI: https://doi.org/10.1016/j.euroneuro.2019.08.047 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​P.1.06 TRKB receptor interaction with postsynaptic density proteins (PSD93 and PSD95) in the mechanism of antidepressants​
    Fred, S.; Casarotto, P.; Moliner, R.; Antila, H.; Schlüter, O.   & Castrén, E.​ (2019) 
    European Neuropsychopharmacology, 29 pp. S636​-S637​.​ DOI: https://doi.org/10.1016/j.euroneuro.2019.01.009 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​High-Throutghtput Antibody-Based Profiling of Serum in Shiziphrenia and Bipolar Disorder Patients: An Integrative Genomics-Proteomics Pilot Study​
    Papiol, S. ; Just, D.; Kannaiyan, N.; Anderson-Schmidt, H. ; Budde, M. ; Gade, K.   & Heilbronner, U.  et al.​ (2019) 
    European Neuropsychopharmacology, 29 pp. S993​-S994​.​ DOI: https://doi.org/10.1016/j.euroneuro.2017.08.378 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​The Use of Genomic Information In Medical Practice: A Survey on People’s Knowledge, Expectations, And Fears​
    Flatau, L.; Umbach, N. ; Sax, U. ; Beißbarth, T. ; Duttge, G. ; Schweda, M.   & Schulze, T.​ (2017) 
    European Neuropsychopharmacology, 27 art. S369​.​ DOI: https://doi.org/10.1016/j.euroneuro.2016.09.396 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Polygenic Burden Analysis of Longitudinal Clusters of Psychopathological Features In A Cross-Diagnostic Group of Individuals with Severe Mental Illness​
    Schulte, E.; Kondofersky, I.; Budde, M. ; Adorjan, K.; Aldinger, F.; Anderson-Schmidt, H.   & Andlauer, T. F. et al.​ (2017) 
    European Neuropsychopharmacology, 27 pp. S401​-S402​.​ DOI: https://doi.org/10.1016/j.euroneuro.2016.09.441 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​POLYGENIC BURDEN ANALYSIS OF LONGITUDINAL CLUSTERS OF QUALITY OF LIFE AND FUNCTIONING IN PATIENTS WITH SEVERE MENTAL ILLNESS​
    Comes, A.; Aldinger, F.; Kondofersky, I.; Adorjan, K.; Anderson-Schmidt, H. ; Andlauer, T. F. & Budde, M.  et al.​ (2017) 
    European Neuropsychopharmacology, 27 pp. S408​-S409​.​ DOI: https://doi.org/10.1016/j.euroneuro.2016.09.450 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Integrating Polygenic Allele Burden Information And Phenomic Data To Characterize Complex Disease Trajectories In Severe Mental Illness​
    Budde, M. ; Kondofersky, I.; Adorjan, K.; Aldinger, F.; Anderson-Schmidt, H. ; Andlauer, T. F. & Flatau, L. et al.​ (2017) 
    European Neuropsychopharmacology, 27 pp. S406​.​ DOI: https://doi.org/10.1016/j.euroneuro.2016.09.447 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Pharmacogenomic aspects of bipolar disorder: An update​
    Budde, M. ; Degner, D. ; Brockmöller, J.   & Schulze, T.​ (2017) 
    European Neuropsychopharmacology, 27(6) pp. 599​-609​.​ DOI: https://doi.org/10.1016/j.euroneuro.2017.02.001 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Dissecting Religious Delusions In Schizophrenia: The Interplay Of Religious Activity And Polygenic Burden​
    Anderson-Schmidt, H. ; Gade, K. ; Malzahn, D. ; Papiol, S. ; Budde, M. ; Kalman, J. & Aldinger, F. et al.​ (2017) 
    European Neuropsychopharmacology, 27 pp. S457​-S458​.​ DOI: https://doi.org/10.1016/j.euroneuro.2016.09.529 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Using Polygenic Scores Based on Schneiderian First Rank Symptoms To Characterize Disease Trajectories In Severe Mental Illnesses​
    Anderson-Schmidt, H. ; Papiol, S. ; Andlauer, T. F.; Heilbronner, U. ; Budde, M. ; Kalman, J. & Degenhardt, F. et al.​ (2017) 
    European Neuropsychopharmacology, 27 pp. S395​-S396​.​ DOI: https://doi.org/10.1016/j.euroneuro.2016.09.433 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Using Machine Learning To Build Individualized Prediction Models Of Future Quality Of Life In Psychosis Patients​
    Kalman, J.; Budde, M. ; Dwyer, D.; Papiol, S. ; Anderson-Schmidt, H. ; Gade, K.   & Heilbronner, U.  et al.​ (2017) 
    European Neuropsychopharmacology, 27 pp. S464​.​ DOI: https://doi.org/10.1016/j.euroneuro.2016.09.539 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Polygenic Risk Scores And Substance Abuse Comorbidity In Patients With Schizophrenia And Bipolar Disorders​
    Adorjan, K.; Papiol, S. ; Gade, K. ; Malzahn, D. ; Budde, M. ; Aldinger, F. & Kalman, J. et al.​ (2017) 
    European Neuropsychopharmacology, 27 pp. S409​.​ DOI: https://doi.org/10.1016/j.euroneuro.2016.09.451 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​The Role Of Micrornas In The Course Of Severe Mental Disorders​
    Heilbronner, U. ; Jain, G.; Kaurani, L. ; Kondofersky, I.; Budde, M. ; Gade, K.   & Kalman, J. et al.​ (2017) 
    European Neuropsychopharmacology, 27 pp. 456​-457​.​ DOI: https://doi.org/10.1016/j.euroneuro.2016.09.527 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Effects of amphetamine on pro-social ultrasonic communication in juvenile rats: Implications for mania models​
    Engelhardt, K.-A.; Fuchs, E.; Schwarting, R. K. & Wöhr, M.​ (2017) 
    European Neuropsychopharmacology, 27(3) pp. 261​-273​.​ DOI: https://doi.org/10.1016/j.euroneuro.2017.01.003 
    ​Details  DOI 
  • 2016 | Conference Abstract
    ​ ​(Epi)genetic regulation of fear sensitivity in mouse models of anxiety​
    Singewald, N.; Maurer, V.; Oberhauser, M.; Wille, A.; Lusser, A.; Sartori, S. & Sah, A. et al.​ (2016)
    European Neuropsychopharmacology, 26 pp. S142​-S143. ​29th Congress of the European-College-of-Neuropsychopharmacology (ECNP)​, Vienna, AUSTRIA.
    Amsterdam​: Elsevier Science Bv.
    ​Details  WoS 
  • 2016 | Journal Article
    ​ ​Neuroligin-family synaptic adhesion proteins in autism spectrum disorders​
    Brose, N. ​ (2016) 
    European Neuropsychopharmacology, 26 pp. S131​.​ DOI: https://doi.org/10.1016/S0924-977X(16)30913-0 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​The inverse link between genetic risk for schizophrenia and migraine through NMDA (N-methyl-D-aspartate) receptor activation via D-serine​
    van der Auwera, S.; Teumer, A.; Hertel, J.; Homuth, G.; Voelker, U.; Lucht, M. J. & Degenhardt, F. A. et al.​ (2016) 
    European Neuropsychopharmacology, 26(9) pp. 1507​-1515​.​ DOI: https://doi.org/10.1016/j.euroneuro.2016.03.019 
    ​Details  DOI  PMID  PMC  WoS 
  • 2016 | Journal Article
    ​ ​Electroconvulsive therapy selectively enhances amyloid beta 1-42 in the cerebrospinal fluid of patients with major depression: A prospective pilot study​
    Kranaster, L.; Aksay, S. S.; Bumb, J. M.; Janke, C.; Alonso, A.; Hoyer, C. & Zerr, I. et al.​ (2016) 
    European Neuropsychopharmacology, 26(12) pp. 1877​-1884​.​ DOI: https://doi.org/10.1016/j.euroneuro.2016.11.004 
    ​Details  DOI  PMID  PMC  WoS 
  • 2015 | Conference Abstract
    ​ ​Structural brain alterations in major depression: findings from the ENIGMA Major Depressive Disorder Working Group​
    Schmaal, L.; Veltman, D. J.; van Erp, T. G.; Saemann, P. G.; Frodl, T.; Jahanshad, N. & Loehrer, E. et al.​ (2015)
    European Neuropsychopharmacology, 25 pp. S394​-S395. ​28th Congress of the European-College-of-Neuropsychopharmacology (ECNP)​, Amsterdam, NETHERLANDS.
    Amsterdam​: Elsevier Science Bv.
    ​Details  WoS 
  • 2015 | Conference Abstract
    ​ ​Chronic psychosocial stress and endocannabinoid system interact to affect the transcription of SLC6A4, in the mouse corticostriatal circuits​
    Roig, J. T.; Piscitelli, F.; Gil, V. & Reinecke, U. H.​ (2015)
    European Neuropsychopharmacology, 25 ​28th Congress of the European-College-of-Neuropsychopharmacology (ECNP)​, Amsterdam, NETHERLANDS.
    Amsterdam​: Elsevier Science Bv.
    ​Details  WoS 
  • 2015 | Journal Article | 
    ​ ​A common risk variant in CACNA1C supports a sex-dependent effect on longitudinal functioning and functional recovery from episodes of schizophrenia-spectrum but not bipolar disorder​
    Heilbronner, U.; Malzahn, D.; Strohmaier, J.; Maier, S.; Frank, J.; Treutlein, J. & Muehleisen, T. W. et al.​ (2015) 
    European Neuropsychopharmacology, 25(12) pp. 2262​-2270​.​ DOI: https://doi.org/10.1016/j.euroneuro.2015.09.012 
    ​Details  DOI  PMID  PMC  WoS 
  • 2015 | Review
    ​ ​Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders?​
    Bayer, T. A.​ (2015)
    European Neuropsychopharmacology, 25​(5) pp. 713​-724​.​
    Elsevier Science Bv. DOI: https://doi.org/10.1016/j.euroneuro.2013.03.007 
    ​Details  DOI  PMID  PMC  WoS 
  • 2014 | Conference Abstract
    ​ ​The genetic foundation​
    Schulze, T. G.​ (2014)
    European Neuropsychopharmacology, 24 , Berlin, GERMANY.
    Amsterdam​: Elsevier Science Bv.
    ​Details  WoS 
  • 2014 | Journal Article
    ​ ​P.2.a.022 Robust efficacy of 3β-methoxy-pregnenolone (MAP4343) in validated animal models of depression suggests a new antidepressant mechanism​
    Froger, N.; Parésys, L.; Fournet, V.; Ladurelle, N.; Cottin, J.; Leandri, J. & Hoffmann, K. et al.​ (2014) 
    European Neuropsychopharmacology, 24 pp. S374​.​ DOI: https://doi.org/10.1016/S0924-977X(14)70597-8 
    ​Details  DOI 
  • 2014 | Journal Article
    ​ ​Agomelatine in the tree shrew model of depression: Effects on stress-induced nocturnal hyperthermia and hormonal status​
    Schmelting, B.; Corbach-Soehle, S.; Kohlhause, S.; Schlumbohm, C.; Fluegge, G. & Fuchs, E.​ (2014) 
    European Neuropsychopharmacology, 24(3) pp. 437​-447​.​ DOI: https://doi.org/10.1016/j.euroneuro.2013.07.010 
    ​Details  DOI  PMID  PMC  WoS 
  • 2014 | Journal Article
    ​ ​BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: Results from a factorial, randomized, sham-controlled trial​
    Brunoni, A. R.; Machado-Vieira, R.; Zarate, C. A. J.; Vieira, E. L. M.; Vanderhasselt, M.-A.; Nitsche, M. A. & Valiengo, L. et al.​ (2014) 
    European Neuropsychopharmacology, 24(7) pp. 1144​-1151​.​ DOI: https://doi.org/10.1016/j.euroneuro.2014.03.006 
    ​Details  DOI  PMID  PMC  WoS 
  • 2012 | Journal Article
    ​ ​Common and distinct neural correlates of emotional processing in Bipolar Disorder and Major Depressive Disorder: A voxel-based meta-analysis of functional magnetic resonance imaging studies​
    Delvecchio, G.; Fossati, P.; Boyer, P.; Brambilla, P.; Falkai, P.; Gruber, O. & Hietala, J. et al.​ (2012) 
    European Neuropsychopharmacology, 22(2) pp. 100​-113​.​ DOI: https://doi.org/10.1016/j.euroneuro.2011.07.003 
    ​Details  DOI  PMID  PMC  WoS 
  • 2012 | Journal Article
    ​ ​P.2.b.009 Regulation of the astrocytic proteins NDRG2 and GFAP in the rat hippocampus by chronic social stress: no reversal by citalopram​
    Flügge, G.; Araya-Callis, C.; Hiemke, C.; Abumaria, N. & Fuchs, E.​ (2012) 
    European Neuropsychopharmacology, 22 pp. S246​.​ DOI: https://doi.org/10.1016/S0924-977X(12)70367-X 
    ​Details  DOI 
  • 2011 | Conference Abstract
    ​ ​Are we doing enough when assessing the effectiveness of our patient's treatment?​
    Falkai, P. G.​ (2011)
    European Neuropsychopharmacology, 21 pp. S632​-S633. ​24th Congress Meeting of European-College-of-Neuropsychopharmacology​, Paris, FRANCE.
    Amsterdam​: Elsevier Science Bv.
    ​Details  WoS 
  • 2011 | Journal Article
    ​ ​Advances in multidisciplinary and cross-species approaches to examine the neurobiology of psychiatric disorders​
    Kas, M. J.; Krishnan, V.; Gould, T. D.; Collier, D. A.; Olivier, B.; Lesch, K.-P. & Domenici, E. et al.​ (2011) 
    European Neuropsychopharmacology, 21(7) pp. 532​-544​.​ DOI: https://doi.org/10.1016/j.euroneuro.2010.12.001 
    ​Details  DOI 
  • 2011 | Journal Article
    ​ ​P.2.b.026 Psychosocial stress affects core body temperature in tree shrews: a new statistical model​
    Bianchi, M.; Bate, S.; Bauerle, R.; Baulieu, E. & Fuchs, E.​ (2011) 
    European Neuropsychopharmacology, 21 pp. S382​-S383​.​ DOI: https://doi.org/10.1016/S0924-977X(11)70614-9 
    ​Details  DOI 
  • 2011 | Journal Article
    ​ ​P.2.b.022 Psychosocial stress in tree shrews induces hormonal alterations accompanied by lateralised cytoskeletal changes in the hippocampus​
    Parésys, L.; Fuchs, E.; Baulieu, E. & Bianchi, M.​ (2011) 
    European Neuropsychopharmacology, 21 pp. S380​.​ DOI: https://doi.org/10.1016/S0924-977X(11)70610-1 
    ​Details  DOI 
  • 2011 | Journal Article
    ​ ​Predictors of response and remission in the acute treatment of first-episode schizophrenia patients - Is it all about early response?​
    Schennach-Wolff, R.; Jaeger, M.; Mayr, A.; Meyer, S. T.; Kuehn, K.-U.; Klingberg, S. & Heuser, I. et al.​ (2011) 
    European Neuropsychopharmacology, 21(5) pp. 370​-378​.​ DOI: https://doi.org/10.1016/j.euroneuro.2010.10.003 
    ​Details  DOI  PMID  PMC  WoS 
  • 2010 | Conference Abstract
    ​ ​Schizophrenia: positive and negative symptom relief​
    Falkai, P. G.​ (2010)
    European Neuropsychopharmacology, 20 ​23rd Congress Meeting of European-College-of-Neuropsychopharmacology​, Amsterdam, NETHERLANDS.
    Amsterdam​: Elsevier Science Bv.
    ​Details  WoS 
  • 2010 | Journal Article
    ​ ​Manifesto for a European Anxiety Disorders Research Network​
    Baldwin, D. S.; Allgulander, C.; Altamura, A. C.; Angst, J.; Bandelow, B.; den Boer, J. A. & Boyer, P. et al.​ (2010) 
    European Neuropsychopharmacology, 20(6) pp. 426​-432​.​ DOI: https://doi.org/10.1016/j.euroneuro.2010.02.015 
    ​Details  DOI  PMID  PMC  WoS 
  • 2010 | Review
    ​ ​Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: Implications for depression and antidepressant action​
    Lucassen, P. J.; Meerlo, P.; Naylor, A. S.; van Dam, A. M.; Dayer, A. G.; Fuchs, E.& Oomen, C. A. et al.​ (2010)
    European Neuropsychopharmacology, 20​(1) pp. 1​-17​.​
    Elsevier Science Bv. DOI: https://doi.org/10.1016/j.euroneuro.2009.08.003 
    ​Details  DOI  PMID  PMC  WoS 
  • 2009 | Conference Abstract
    ​ ​Clinical suitability of GAD-7 scale compared to hospital anxiety and depression scale-A for monitoring treatment effects in generalized anxiety disorder​
    Bandelow, B. & Brasser, M.​ (2009)
    European Neuropsychopharmacology, 19 pp. S604​-S605. ​22nd Congress of the European-College-of-Neuropsychopharmacology​, Istanbul, TURKEY.
    Amsterdam​: Elsevier Science Bv.
    ​Details  WoS 
  • 2009 | Conference Abstract
    ​ ​Paradigm shift in Abeta toxicity​
    Bayer, T.   & Wirths, O. ​ (2009)
    European Neuropsychopharmacology, 19 ​22nd Congress of the European-College-of-Neuropsychopharmacology​, Istanbul, TURKEY.
    Amsterdam​: Elsevier Science Bv.
    ​Details  WoS 
  • 2009 | Conference Abstract
    ​ ​Symptom improvement and functional recovery in patients with anxiety disorders​
    Baldwin, D. S.; Bandelow, B.; Dolberg, O. T.; Andersen, H. F. & Stein, D. J.​ (2009)
    European Neuropsychopharmacology, 19 pp. S590​-S591. ​22nd Congress of the European-College-of-Neuropsychopharmacology​, Istanbul, TURKEY.
    Amsterdam​: Elsevier Science Bv.
    ​Details  WoS 
  • 2009 | Conference Abstract
    ​ ​Comorbid depression and anxiety - understanding and treating complex patients​
    Bandelow, B.​ (2009)
    European Neuropsychopharmacology, 19 ​22nd Congress of the European-College-of-Neuropsychopharmacology​, Istanbul, TURKEY.
    Amsterdam​: Elsevier Science Bv.
    ​Details  WoS 
  • 2009 | Conference Abstract
    ​ ​Can switching antipsychotics improve patient outcomes?​
    Falkai, P. G.​ (2009)
    European Neuropsychopharmacology, 19 ​22nd Congress of the European-College-of-Neuropsychopharmacology​, Istanbul, TURKEY.
    Amsterdam​: Elsevier Science Bv.
    ​Details  WoS 
  • 2009 | Journal Article
    ​ ​Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice​
    Goodwin, G.; Fleischhacker, W. W.; Arango, C.; Baumann, P.; Davidson, M. W.; de Hert, M. & Falkai, P. et al.​ (2009) 
    European Neuropsychopharmacology, 19(7) pp. 520​-532​.​ DOI: https://doi.org/10.1016/j.euroneuro.2009.04.003 
    ​Details  DOI  PMID  PMC  WoS 
  • 2008 | Journal Article
    ​ ​S.16.04 Neurogenesis in the adult brain – is there an association with stress and depression?​
    Fuchs, E.​ (2008) 
    European Neuropsychopharmacology, 18 pp. S179​.​ DOI: https://doi.org/10.1016/S0924-977X(08)70176-7 
    ​Details  DOI 
  • 2008 | Journal Article
    ​ ​P.2.d.006 Effects of agomelatine and S32006, a selective 5-HT2C receptor antagonist, in chronically-stressed tree shrews​
    Fuchs, E.; Corbach-Söhle, S.; Schmelting, B.; Mocaer, E.; Millan, M. & Gabriel-Gracia, C.​ (2008) 
    European Neuropsychopharmacology, 18 pp. S348​.​ DOI: https://doi.org/10.1016/S0924-977X(08)70488-7 
    ​Details  DOI 
  • 2008 | Journal Article
    ​ ​P.2.d.002 Effects of chronic social stress and fluoxetine treatment on the vascular niche and neurogenesis in the hippocampus​
    Czéh, B. & Fuchs, E.​ (2008) 
    European Neuropsychopharmacology, 18 pp. S346​.​ DOI: https://doi.org/10.1016/S0924-977X(08)70484-X 
    ​Details  DOI 
  • 2008 | Journal Article
    ​ ​Limitations of current therapies: Why do patients switch therapies?​
    Falkai, P.​ (2008) 
    European Neuropsychopharmacology, 18 pp. S135​-S139​.​ DOI: https://doi.org/10.1016/j.euroneuro.2008.04.003 
    ​Details  DOI  PMID  PMC  WoS 
  • 2008 | Journal Article
    ​ ​Switching schizophrenia patients from typical neuroleptics to olanzapine: Effects on BOLD response during attention and working memory​
    Schlagenhauf, F.; Wuestenberg, T.; Schmack, K.; Dinges, M.; Wrase, J.; Koslowski, M. & Kienast, T. et al.​ (2008) 
    European Neuropsychopharmacology, 18(8) pp. 589​-599​.​ DOI: https://doi.org/10.1016/j.euroneuro.2008.04.013 
    ​Details  DOI  PMID  PMC  WoS 
  • 2007 | Conference Abstract
    ​ ​Treatment-resistant panic anxiety disorder​
    Bandelow, B.​ (2007)
    European Neuropsychopharmacology, 17 pp. S207​-S208. ​20th Congress of the European-College-of-Neuropsychopharmacology​, Vienna, AUSTRIA.
    Amsterdam​: Elsevier Science Bv. DOI: https://doi.org/10.1016/S0924-977X(07)70257-2 
    ​Details  DOI  WoS 
  • 2007 | Conference Abstract
    ​ ​Combination treatments beyond antipsychotic polypharmacy​
    Falkai, P. G. & Wobrock, T.​ (2007)
    European Neuropsychopharmacology, 17 ​20th Congress of the European-College-of-Neuropsychopharmacology​, Vienna, AUSTRIA.
    Amsterdam​: Elsevier Science Bv. DOI: https://doi.org/10.1016/S0924-977X(07)70241-9 
    ​Details  DOI  WoS 
  • 2007 | Journal Article
    ​ ​S.2.2 Stress models and mechanisms in primates​
    Fuchs, E.​ (2007) 
    European Neuropsychopharmacology, 17 pp. S39​-S40​.​ DOI: https://doi.org/10.1016/S0924-977X(07)70045-7 
    ​Details  DOI 
  • 2007 | Journal Article
    ​ ​P.2.d.005 Comparison of agomelatine and melatonin for effects in chronically stressed tree shrews, an animal model of depression​
    Corbach, S.; Schmelting, B.; Fuchs, E. & Mocaer, E.​ (2007) 
    European Neuropsychopharmacology, 17 pp. S364​-S365​.​ DOI: https://doi.org/10.1016/S0924-977X(07)70534-5 
    ​Details  DOI 
  • 2007 | Journal Article
    ​ ​P.1.15 Expression of neuron-specific enolase in the hippocampus of rats: regional effects of chronic stress and citalopram​
    Abumaria, N. & Flügge, G.​ (2007) 
    European Neuropsychopharmacology, 17 pp. S14​-S15​.​ DOI: https://doi.org/10.1016/S0924-977X(07)70016-0 
    ​Details  DOI 
  • 2007 | Journal Article
    ​ ​Effect of chronic citalopram on serotonin-related and stress-regulated genes in the dorsal raphe nucleus of the rat​
    Abumaria, N.; Rygula, R.; Hiemke, C.; Fuchs, E.; Havemann-Reinecke, U.; Ruether, E. & Fluegge, G.​ (2007) 
    European Neuropsychopharmacology, 17(6-7) pp. 417​-429​.​ DOI: https://doi.org/10.1016/j.euroneuro.2006.08.009 
    ​Details  DOI  PMID  PMC  WoS 
  • 2006 | Conference Abstract
    ​ ​Generalized anxiety disorder (GAD): the treatment implications of clinical heterogeneity​
    Bandelow, B.​ (2006)
    European Neuropsychopharmacology, 16 ​19th Congress of the European-College-of-Neuropsychopharmacology​, Paris, FRANCE.
    Amsterdam​: Elsevier Science Bv. DOI: https://doi.org/10.1016/S0924-977X(06)70835-5 
    ​Details  DOI  WoS 
  • 2006 | Conference Abstract
    ​ ​Expression of genes related to 5-HT neurotransmission: regulation by citalopram in a rat model of depression​
    Flugge, G.; Abumaria, R.; Rygula, R. & Fuchs, E.​ (2006)
    European Neuropsychopharmacology, 16 ​19th Congress of the European-College-of-Neuropsychopharmacology​, Paris, FRANCE.
    Amsterdam​: Elsevier Science Bv. DOI: https://doi.org/10.1016/S0924-977X(06)70315-7 
    ​Details  DOI  WoS 
  • 2006 | Conference Abstract
    ​ ​Which factors predict placebo response in anxiety disorders and major depression?​
    Stein, D. J.; Baldwin, D. S.; Dolberg, O. T.; Despiegel, N. & Bandelow, B.​ (2006)
    European Neuropsychopharmacology, 16 ​19th Congress of the European-College-of-Neuropsychopharmacology​, Paris, FRANCE.
    Amsterdam​: Elsevier Science Bv. DOI: https://doi.org/10.1016/S0924-977X(06)70618-6 
    ​Details  DOI  WoS 
  • 2006 | Journal Article
    ​ ​S.27.03 Prenatal stress affects behaviour, neuroendocrine systems and hippocampal structure of primates in a persistent manner​
    Fuchs, E.​ (2006) 
    European Neuropsychopharmacology, 16 pp. S203​.​ DOI: https://doi.org/10.1016/S0924-977X(06)70128-6 
    ​Details  DOI 
  • 2006 | Journal Article
    ​ ​P.2.d.011 Effects of the novel antidepressant agomelatine (S 20098) and fluoxetine in chronically stressed tree shrews, an animal model of depression​
    Fuchs, E.; Schmelting, B. & Mocaër, E.​ (2006) 
    European Neuropsychopharmacology, 16 pp. S338​-S339​.​ DOI: https://doi.org/10.1016/S0924-977X(06)70382-0 
    ​Details  DOI 
  • 2005 | Conference Abstract
    ​ ​ADHD over the life span (diagnosis and course)​
    Rothenberger, A.​ (2005)
    European Neuropsychopharmacology, 15 ​18th ECNP Congress 2005​, Amsterdam, NETHERLANDS.
    Amsterdam​: Elsevier Science Bv.
    ​Details  WoS 
  • 2005 | Conference Abstract
    ​ ​Methamphetamine and other stimulants​
    Huether, G.​ (2005)
    European Neuropsychopharmacology, 15 ​18th ECNP Congress 2005​, Amsterdam, NETHERLANDS.
    Amsterdam​: Elsevier Science Bv.
    ​Details  WoS 
  • 2005 | Conference Abstract
    ​ ​Treatment of anxiety disorders​
    Bandelow, B.​ (2005)
    European Neuropsychopharmacology, 15 ​8th Regional Meeting of the European Congress of Neuropathology​, Moscow, RUSSIA.
    Amsterdam​: Elsevier Science Bv. DOI: https://doi.org/10.1016/S0924-977X(05)80218-4 
    ​Details  DOI  WoS 
  • 2004 | Conference Abstract
    ​ ​EEG abnormalities in patients treated with quetiapine​
    Degner, D.; Ruther, E.; Akkan, R. & Bleich, S.​ (2004)
    European Neuropsychopharmacology, 14 ​17th Congress of the European-College-of-Neuropsychopharmacology​, Stockholm, SWEDEN.
    Amsterdam​: Elsevier Science Bv. DOI: https://doi.org/10.1016/S0924-977X(04)80318-3 
    ​Details  DOI  WoS 
  • 2004 | Conference Paper
    ​ ​Alterations of neuroplasticity in depression: the hippocampus and beyond​
    Fuchs, E.; Czeh, B.; Kole, M.; Michaelis, T. & Lucassen, P. J.​ (2004)
    European Neuropsychopharmacology, 14 pp. S481​-S490. ​24th Congress of the Collegium-Internationale-Neuro-Psychopharmacologicum​, Paris, FRANCE.
    Amsterdam​: Elsevier Science Bv. DOI: https://doi.org/10.1016/j.euroneuro.2004.09.002 
    ​Details  DOI  PMID  PMC  WoS 
  • 2003 | Journal Article
    ​ ​5-HT1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo​
    Broocks, A.; Meyer, T.; Opitz, M.; Bartmann, U.; Hillmer-Vogel, U.; George, A. & Pekrun, G. et al.​ (2003) 
    European Neuropsychopharmacology, 13(3) pp. 153​-164​.​ DOI: https://doi.org/10.1016/S0924-977X(02)00177-3 
    ​Details  DOI  PMID  PMC  WoS 
  • 2003 | Conference Abstract
    ​ ​Homocysteine induces cell death of astrocytes in vitro​
    Maler, M.; Wiltfang, J.; Degner, D.; Kornhuber, J. & Bleich, S.​ (2003)
    European Neuropsychopharmacology, 13 ​16th Congress of the European-College-of-Neuropsychopharmacology​, PRAGUE, CZECH REPUBLIC.
    Amsterdam​: Elsevier Science Bv. DOI: https://doi.org/10.1016/S0924-977X(03)92244-9 
    ​Details  DOI  WoS 
  • 2003 | Conference Abstract
    ​ ​Treatment of acutely exacerbated including highly agitated schizophrenic patients with oral risperidone​
    Schreiner, A.; Pajonk, F. Pajonk, Frank-Gerald B.; Peters, S. & Ruether, E.​ (2003)
    European Neuropsychopharmacology, 13 ​16th Congress of the European-College-of-Neuropsychopharmacology​, PRAGUE, CZECH REPUBLIC.
    Amsterdam​: Elsevier Science Bv. DOI: https://doi.org/10.1016/S0924-977X(03)91996-1 
    ​Details  DOI  WoS 
  • 2003 | Conference Abstract
    ​ ​Apolipoprotein E epsilon 4 is associated with hippocampal volume reduction in females with alcoholism​
    Bleich, S.; Wilhelm, J.; Degner, D.; Sperling, W. & Kornhuber, J.​ (2003)
    European Neuropsychopharmacology, 13 pp. S420​-S421. ​16th Congress of the European-College-of-Neuropsychopharmacology​, PRAGUE, CZECH REPUBLIC.
    Amsterdam​: Elsevier Science Bv. DOI: https://doi.org/10.1016/S0924-977X(03)92282-6 
    ​Details  DOI  WoS 
  • 2003 | Conference Abstract
    ​ ​Autoimmune thyroiditis (AIT) and affective disorders - a prospective pilot study​
    Degner, D.; Bleich, S.; Haust, M.; Zerr, I.; Ruther, E. & Meller, J.​ (2003)
    European Neuropsychopharmacology, 13 ​16th Congress of the European-College-of-Neuropsychopharmacology​, PRAGUE, CZECH REPUBLIC.
    Amsterdam​: Elsevier Science Bv. DOI: https://doi.org/10.1016/S0924-977X(03)91847-5 
    ​Details  DOI  WoS 
  • 2002 | Conference Abstract
    ​ ​Sertraline versus paroxetine in the treatment of panic disorder: A multinational randomized double-blind 15 week study​
    Bandelow, B.; Behnke, K.; Lenoir, S.; Hendriks, G. J.; Alkin, T.; Dombrowski, A. & Goebel, C.​ (2002)
    European Neuropsychopharmacology, 12 
    Amsterdam​: Elsevier Science Bv.
    ​Details  WoS 
  • 2002 | Conference Abstract
    ​ ​How long to treat anxiety disorders?​
    Bandelow, B.​ (2002)
    European Neuropsychopharmacology, 12 pp. S159​-S160. 
    Amsterdam​: Elsevier Science Bv.
    ​Details  WoS 

Type

Subtype

Date issued

Publication Affiliation

Fulltext

Options

Citation Style

GRO View APA Chicago MLA Vancouver

Sort

Issue Date
ASC DESC
Title
ASC DESC

Embed

JavaScript
Link

Export

Activate Export Mode
Deactivate Export Mode

Select some or all items (max. 800 for CSV/Excel) from the publications list, then choose an export format below.